Andrew A. F. Hack

Chief Financial Officer, Editas Medicine.

Companies

Mersana Therapeutics (United States)Board member Jun 27, 2017 to now¹
Nuvalent, Inc.Board member Jul 28, 2021 to Dec 13, 2024²
DYNAVAX TECHNOLOGIES CORPBoard member Aug 14, 2019 to Aug 10, 2023³
Allena Pharmaceuticals, Inc.Board member Jun 12, 2018 to Nov 18, 2020⁴
Atea Pharmaceuticals, Inc.Board member Oct 29, 2020 to Nov 3, 2020⁵
BCLS Acquisition Corp.Board member Oct 21, 2020 to Oct 26, 2020⁶
BCLS Acquisition Corp.Chief financial officer Oct 21, 2020 to Oct 26, 2020⁶
Editas MedicineChief financial officer Feb 2, 2016 to Feb 6, 2019⁷

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARMersana Therapeutics (United States), Board member
2
SEC EDGARNuvalent, Inc., Board member
3
SEC EDGARDYNAVAX TECHNOLOGIES CORP, Board member
4
SEC EDGARAllena Pharmaceuticals, Inc., Board member
5
SEC EDGARAtea Pharmaceuticals, Inc., Board member
6
SEC EDGARBCLS Acquisition Corp., Board member
7
SEC EDGAREditas Medicine, Chief financial officer